Syntec Optics (NASDAQ:OPTX), a leading provider of mission-critical technologies for vibrant end-markets - defense tech, space tech, and biomed tech today announced it received nearly $4 million in U.S. life sciences purchase orders. 

As the quality of healthcare in the U.S. advances, Syntec Optics is playing a pivotal role in providing the high-precision optical products required for existing and next-generation technologies.